Aliskiren inhibits atherosclerosis development and improves plaque stability in APOE*3Leiden.CETP transgenic mice with or without treatment with atorvastatin.


Abstract

Aliskiren inhibited atherosclerosis development and improved plaque stability alone and in combination with atorvastatin, possibly via a mechanism involving T cells.

These results suggest a potential benefit of using aliskiren in a clinical setting, particularly in combination with statin treatment.


Full Text


Subjects


Similar articles

Authors


Publication date

2011-12-14


Journal

Journal of hypertension
J Hypertens (1473-5598)

Journal topics


Language

Eng.


Copyright

TNO Metabolic Health Research, Leiden University Medical Center, Leiden, The Netherlands. susan.jordaan [at] tno.nl


Release reference

J Hypertens. 2012 Jan;30(1):107-16



Related books


Español | English

© Galenicom 1999-2013